Literature DB >> 12876412

Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years).

Rája Lodinová-Zádníková1, Bozena Cukrowska, Helena Tlaskalova-Hogenova.   

Abstract

BACKGROUND: The development of allergies is a complex in which both composition and influence of the intestinal flora play an important role. We observed in earlier studies that the presence of an orally administered probiotic Escherichia coli strain in the intestine stimulated both a serum and local antibody response, decreased the presence of pathogens, the number of infections and the need for antibiotics.
METHODS: The preventive effect of oral colonization after birth with a probiotic E. COLI strain was assessed by evaluating the results of a questionnaire both 20 years (150 full-term infants) and 10 years (77 preterm infants) after colonization.
RESULTS: Differences in occurrence of allergies in colonized and control subjects were statistically significant both after 10 and 20 years (p < 0.01). Specific serum IgE antibodies confirmed the presence of allergies in 100% of 10-year-old and 91% of 20-year-old patients with clinical symptoms of allergy. Ten years after colonization, the occurrence of repeated infections was significantly lower in colonized subjects than it was in controls (p < 0.01); 20 years later, no differences were found in these groups.
CONCLUSIONS: Intentional colonization of the intestine with E. coli after birth (offering the advantage of the first colonizer) was found to decrease the incidence of allergies and repeated infections in later life. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876412     DOI: 10.1159/000071488

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  21 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Microbiota restoration: natural and supplemented recovery of human microbial communities.

Authors:  Gregor Reid; Jessica A Younes; Henny C Van der Mei; Gregory B Gloor; Rob Knight; Henk J Busscher
Journal:  Nat Rev Microbiol       Date:  2010-11-29       Impact factor: 60.633

Review 3.  Probiotics manipulate host cytokine response and induce antimicrobial peptides.

Authors:  I Trebichavský; I Splíchal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Probiotic Lactobacillus strains: in vitro and in vivo studies.

Authors:  B Cukrowska; I Motyl; H Kozáková; M Schwarzer; R K Górecki; E Klewicka; K Slizewska; Z Libudzisz
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

5.  Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization.

Authors:  Hana Kozakova; Martin Schwarzer; Ludmila Tuckova; Dagmar Srutkova; Elzbieta Czarnowska; Ilona Rosiak; Tomas Hudcovic; Irma Schabussova; Petra Hermanova; Zuzana Zakostelska; Tamara Aleksandrzak-Piekarczyk; Anna Koryszewska-Baginska; Helena Tlaskalova-Hogenova; Bozena Cukrowska
Journal:  Cell Mol Immunol       Date:  2015-03-23       Impact factor: 11.530

6.  The role of probiotics in allergic diseases.

Authors:  Sonia Michail
Journal:  Allergy Asthma Clin Immunol       Date:  2009-10-22       Impact factor: 3.406

Review 7.  Probiotics and human health: a clinical perspective.

Authors:  H S Gill; F Guarner
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

8.  Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Authors:  Lenka Frol'ová; Karel Smetana; Dana Borovská; Andrea Kitanovicová; Klára Klimesová; Ivana Janatková; Karin Malícková; Milan Lukás; Pavel Drastich; Zdenek Benes; Ludmila Tucková; Joachim C Manning; Sabine André; Hans-Joachim Gabius; Helena Tlaskalová-Hogenová
Journal:  Inflamm Res       Date:  2009-03-07       Impact factor: 4.575

9.  Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

Authors:  Miriam Schlee; Jan Wehkamp; Artur Altenhoefer; Tobias A Oelschlaeger; Eduard F Stange; Klaus Fellermann
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Prevention and treatment of urinary tract infection with probiotics: Review and research perspective.

Authors:  D Borchert; L Sheridan; A Papatsoris; Z Faruquz; J M Barua; I Junaid; Y Pati; F Chinegwundoh; N Buchholz
Journal:  Indian J Urol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.